Regulatory Efficacy of Brown Seaweed Lessonia nigrescens Extract on the Gene Expression Profile and Intestinal Microflora in Type 2 Diabetic Mice

Mol Nutr Food Res. 2018 Feb;62(4). doi: 10.1002/mnfr.201700730. Epub 2018 Jan 12.

Abstract

Scope: In this study, the antidiabetic activity of Lessonia nigrescens ethanolic extract (LNE) is investigated in streptozotocin (SZT)-induced type 2 diabetic mice fed with a high-sucrose/high-fat diet.

Methods and results: Ultra high performance liquid chromatography coupled with photo-DAD and electospray ionization-mass spectrometry (ESI-MS) is employed to analyze the major compounds in LNE. The components of the intestinal microflora in type 2 diabetic mice are analyzed by high-throughput next-generation 16S rRNA gene sequencing. Fasting blood glucose levels in diabetic mice are significantly decreased after LNE administration. The histology reveals that LNE could protect the cellular architecture of liver and kidney. LNE treatment significantly increases Bacteroidetes and decreases Firmicutes populations in intestinal microflora. Specifically, It could selectively enrich the amounts of beneficial bacteria, Barnesiella, as well as reduce the abundances of Clostridium and Alistipes. The increased gene and protein expression levels of phosphatidylinositol 3-kinase (PI3K) in the liver are observed in LNE treatment groups, while the expressions of c-Jun N-terminal kinase (JNK) are significantly downregulated.

Conclusion: The above findings suggest that LNE could be considered as a functional food for reducing blood glucose and regulating intestinal microflora.

Keywords: Lessonia nigrescens; anti-diabetic activity; high-throughput 16S rRNA gene sequencing; intestinal microflora; signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology
  • Gastrointestinal Microbiome / drug effects*
  • Liver / metabolism
  • Liver / pathology
  • Male
  • Mice
  • Mice, Inbred ICR
  • Mitogen-Activated Protein Kinase 8 / analysis
  • Mitogen-Activated Protein Kinase 8 / genetics
  • Phosphatidylinositol 3-Kinases / analysis
  • Phosphatidylinositol 3-Kinases / genetics
  • Seaweed*
  • Transcriptome*

Substances

  • Blood Glucose
  • Phosphatidylinositol 3-Kinases
  • Mitogen-Activated Protein Kinase 8